Biomedical engineering guide

Immunoassay Analyzer Buying Guide

Immunoassay Analyzer procurement guide for hospital teams covering what to define before buying, mandatory and preferred specifications, vendor comparison, demonstration questions, site responsibility, warranty, service, TCO, and acceptance conditions.

Biomedical EngineersClinical UsersProcurement TeamsHospital AdministratorsService Engineers

Original vendor-neutral diagram

Laboratory analyzer workflow

Laboratory analyzer workflow for immunoassay-analyzer-buying-guide Immunoassay Analyzer Buying GuideHigh-level sample pathway from identification and preparation through analysis, quality control, validation, and LIS reporting.1
Sample identification
2
Preparation and loading
3
Measurement process
4
Calibration and quality control
5
Validation and LIS result
System boundaries and exact architecture vary by equipment and manufacturer.
Editorial context: Procurement should evaluate throughput against the actual test menu, sample handling, reagent dependency, QC materials, downtime workflow, middleware or LIS interfaces, and service coverage.

Procurement Starting Point

Immunoassay analyzer procurement for assay menu, reagent rental risk, calibration, QC, throughput, and uptime.

Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.

Separate mandatory clinical applications from optional software packages. Require site-planning documents, high-cost component warranty, DICOM testing, and acceptance image-quality baseline before award.

Clinical use should define modality-specific cases, patient volume, reporting workflow, emergency use, contrast workflow where relevant, and image storage/retrieval expectations.

Define Before Buying

  • Clinical use should define modality-specific cases, patient volume, reporting workflow, emergency use, contrast workflow where relevant, and image storage/retrieval expectations.
  • Review patient scheduling, preparation, acquisition, image reconstruction/review, DICOM transfer, reporting, archiving, repeat-image handling, cleaning, and downtime response.
  • Confirm power, UPS policy, HVAC, shielding or MRI safety zoning, room size, control area, floor loading, delivery route, network drops, PACS/RIS readiness, and service clearance.
  • Replace when critical assays or reagents are discontinued, pack size/wastage makes testing uneconomic, pipetting/detection reliability declines, QC failures rise, or software/LIS/service support ends.

User Requirement Checklist

  • Review patient scheduling, preparation, acquisition, image reconstruction/review, DICOM transfer, reporting, archiving, repeat-image handling, cleaning, and downtime response.
  • Radiology users should test positioning, protocol selection, image review, dose or safety indicators, report/export workflow, contrast workflow where applicable, and ergonomic impact during peak lists.
  • Demonstrate sample loading, calibration/QC, result review, error handling, LIS transfer, cleaning/decontamination, and daily shutdown.
  • Laboratory and biomedical teams should review reagent storage, expiry, QC failure response, and service report examples.

Mandatory vs Preferred Specifications

Mandatory requirements

  • Specify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS.
  • Image-chain configuration, clinical application package, dose or safety controls where relevant, workstation/reporting workflow, DICOM/PACS/RIS connectivity, cybersecurity, and site planning requirements should be specified.
  • High-cost components such as tube, detector, probe, coil, workstation, injector head, chiller, software licenses, and service tools should have clear warranty and replacement pricing.
  • Test menu or functional purpose, throughput, sample capacity, calibration/QC method, reagent/consumable requirements, data export/LIS interface, and user permission controls.
  • Environmental requirements including temperature, humidity, ventilation, bench/floor space, water/drain where relevant, power, UPS policy, and biosafety workflow.
  • Service support covering PM, calibration, QC troubleshooting, reagent availability, critical spare parts, and downtime workaround.

Preferred or optional requirements

  • Autoloading, barcode workflow, bidirectional LIS, expanded assay menu, onboard refrigeration, remote diagnostics, or backup analyzer strategy.
  • Extended reagent/consumable pricing lock, QC package, or application support.

Configuration Choices

  • Include assay reagent packs, calibrators, controls, sample cups/racks, trigger/pre-trigger or wash solutions, solid waste containers, pipette consumables where used, UPS, barcode/LIS accessories, and startup menu stock.
  • Price QA phantoms, positioning aids, probes/coils/detectors where applicable, injector accessories, software licenses, workstations, UPS/chiller items, DICOM licenses, and startup consumables.
  • Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.
  • Separate mandatory clinical applications from optional software packages. Require site-planning documents, high-cost component warranty, DICOM testing, and acceptance image-quality baseline before award.
DecisionHow to DecideProcurement Risk
Clinical and performance configurationSpecify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS.Do not compare cost per test from list price while ignoring pack size, onboard stability, calibration frequency, controls, trigger/wash solutions, low-volume wastage, and service response for urgent assays.
Complete operating packageInclude assay reagent packs, calibrators, controls, sample cups/racks, trigger/pre-trigger or wash solutions, solid waste containers, pipette consumables where used, UPS, barcode/LIS accessories, and startup menu stock.An incomplete immunoassay analyzer package creates immediate variation orders, workflow gaps, or incompatible consumables.
Service and ownership modelImmunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.Replace when critical assays or reagents are discontinued, pack size/wastage makes testing uneconomic, pipetting/detection reliability declines, QC failures rise, or software/LIS/service support ends.
Site and implementation scopeConfirm power, UPS policy, HVAC, shielding or MRI safety zoning, room size, control area, floor loading, delivery route, network drops, PACS/RIS readiness, and service clearance.Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.

Vendor Comparison and Demonstration

Vendor comparison points

  • Vendor can demonstrate full patient-to-PACS workflow, QA process, error-log/service process, software licenses, high-cost component coverage, and uptime response.
  • Define test menu, throughput, sample type, reagent model, calibration/QC workflow, LIS connectivity, environmental limits, power backup need, biosafety considerations, and downtime plan.
  • Compare analyzer cost with reagent, QC, calibrator, controls, service, calibration, temperature monitoring, and software/interface costs.

Demonstration questions

  • Demonstrate sample loading, calibration/QC, result review, error handling, LIS transfer, cleaning/decontamination, and daily shutdown.
  • Laboratory and biomedical teams should review reagent storage, expiry, QC failure response, and service report examples.

Technical Evaluation Criteria

  • Specify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS.
  • Image-chain configuration, clinical application package, dose or safety controls where relevant, workstation/reporting workflow, DICOM/PACS/RIS connectivity, cybersecurity, and site planning requirements should be specified.
  • High-cost components such as tube, detector, probe, coil, workstation, injector head, chiller, software licenses, and service tools should have clear warranty and replacement pricing.
  • Vendor can demonstrate full patient-to-PACS workflow, QA process, error-log/service process, software licenses, high-cost component coverage, and uptime response.
Scoring AreaEvidence to RequestWhy It Matters
Clinical fitReview patient scheduling, preparation, acquisition, image reconstruction/review, DICOM transfer, reporting, archiving, repeat-image handling, cleaning, and downtime response.Clinical use should define modality-specific cases, patient volume, reporting workflow, emergency use, contrast workflow where relevant, and image storage/retrieval expectations.
Technical complianceSpecify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS.Acceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.
Service readinessBiomedical should review QA/phantom requirements, calibration, service access, error logs, software versions, high-cost component warranty, remote service, and downtime escalation.Common faults include detector/probe/coil failure, tube wear, chiller/HVAC problems, calibration drift, image artifacts, network/DICOM failures, workstation license issues, and high-cost board failures.
Lifecycle costImmunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.Replace when critical assays or reagents are discontinued, pack size/wastage makes testing uneconomic, pipetting/detection reliability declines, QC failures rise, or software/LIS/service support ends.

Accessories, Consumables and Options to Price

  • Include assay reagent packs, calibrators, controls, sample cups/racks, trigger/pre-trigger or wash solutions, solid waste containers, pipette consumables where used, UPS, barcode/LIS accessories, and startup menu stock.
  • Price QA phantoms, positioning aids, probes/coils/detectors where applicable, injector accessories, software licenses, workstations, UPS/chiller items, DICOM licenses, and startup consumables.
  • Reagents, controls, calibrators, sample cups/tubes, racks, rotors, pipettes/adapters, printer/barcode accessories, UPS where justified, and startup consumables.
  • Temperature logs, calibration tools, waste containers, cleaning materials, and documentation binders.

Site Responsibility Matrix

  • Confirm power, UPS policy, HVAC, shielding or MRI safety zoning, room size, control area, floor loading, delivery route, network drops, PACS/RIS readiness, and service clearance.
ResponsibilityVendor Must StateHospital Must Confirm
Site readinessConfirm power, UPS policy, HVAC, shielding or MRI safety zoning, room size, control area, floor loading, delivery route, network drops, PACS/RIS readiness, and service clearance.Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.
Workflow and interfaceReview patient scheduling, preparation, acquisition, image reconstruction/review, DICOM transfer, reporting, archiving, repeat-image handling, cleaning, and downtime response.Radiology users should test positioning, protocol selection, image review, dose or safety indicators, report/export workflow, contrast workflow where applicable, and ergonomic impact during peak lists.
Accessories and consumablesInclude assay reagent packs, calibrators, controls, sample cups/racks, trigger/pre-trigger or wash solutions, solid waste containers, pipette consumables where used, UPS, barcode/LIS accessories, and startup menu stock.Immunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.
AcceptanceAcceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.Vendor can demonstrate full patient-to-PACS workflow, QA process, error-log/service process, software licenses, high-cost component coverage, and uptime response.

Warranty, Service and TCO Comparison

Warranty and service comparison

  • Biomedical should review QA/phantom requirements, calibration, service access, error logs, software versions, high-cost component warranty, remote service, and downtime escalation.
  • PM should include image quality QA, safety checks, calibration, software/log review, cleaning, mechanical movement checks, cooling/HVAC review, DICOM test, and baseline performance documentation.
  • Request five-year reagent/consumable, QC/calibrator, PM, calibration, spare-parts, application support, labor, travel, and post-warranty pricing.
  • Define support for QC failure, interface downtime, reagent stockout, emergency service, and loaner or backup workflow where critical.

Total cost of ownership items

  • Immunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.
  • TCO includes high-cost components, room works, power/HVAC, QA tools, software licenses, service contract, tube/probe/coil/detector risk, downtime, upgrades, and PACS storage.

Replacement and upgrade exposure

  • Replace when critical assays or reagents are discontinued, pack size/wastage makes testing uneconomic, pipetting/detection reliability declines, QC failures rise, or software/LIS/service support ends.
  • Replace when image quality, dose/safety, software security, parts support, PACS compatibility, or workflow no longer meets clinical service needs.
  • Trends include broader menus, faster STAT channels, compact random-access platforms, improved interference flags, automation connectivity, remote QC, and consolidation with chemistry modules.
  • Relevant trends include AI reconstruction, dose reduction, automated workflow, cybersecurity patching, remote service, structured reporting, and improved detector/probe technology.

Acceptance Requirements Before Award

  • Acceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.
  • Acceptance should include installation qualification, calibration/QC records, LIS transfer test, temperature/environment record, training, manuals, reagent startup stock, and PM schedule.
  • Do not accept until QC and connectivity are demonstrated with the hospital's actual workflow.

Common Buying Mistakes

  • Do not compare cost per test from list price while ignoring pack size, onboard stability, calibration frequency, controls, trigger/wash solutions, low-volume wastage, and service response for urgent assays.
  • Buying imaging equipment without PACS/RIS testing and site responsibility matrix.
  • Ignoring tube/probe/coil/detector warranty, software licenses, QA tools, HVAC, and room readiness.

Buyer Checklist

  • Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.
  • Separate mandatory clinical applications from optional software packages. Require site-planning documents, high-cost component warranty, DICOM testing, and acceptance image-quality baseline before award.
  • Vendor can demonstrate full patient-to-PACS workflow, QA process, error-log/service process, software licenses, high-cost component coverage, and uptime response.
  • Acceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.

Immunoassay Analyzer: Configuration Decision Matrix

DecisionHow to DecideProcurement Risk
Clinical and performance configurationSpecify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS.Do not compare cost per test from list price while ignoring pack size, onboard stability, calibration frequency, controls, trigger/wash solutions, low-volume wastage, and service response for urgent assays.
Complete operating packageInclude assay reagent packs, calibrators, controls, sample cups/racks, trigger/pre-trigger or wash solutions, solid waste containers, pipette consumables where used, UPS, barcode/LIS accessories, and startup menu stock.An incomplete immunoassay analyzer package creates immediate variation orders, workflow gaps, or incompatible consumables.
Service and ownership modelImmunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.Replace when critical assays or reagents are discontinued, pack size/wastage makes testing uneconomic, pipetting/detection reliability declines, QC failures rise, or software/LIS/service support ends.
Site and implementation scopeConfirm power, UPS policy, HVAC, shielding or MRI safety zoning, room size, control area, floor loading, delivery route, network drops, PACS/RIS readiness, and service clearance.Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.

Immunoassay Analyzer: Vendor Evaluation Scoring Prompts

Scoring AreaEvidence to RequestWhy It Matters
Clinical fitReview patient scheduling, preparation, acquisition, image reconstruction/review, DICOM transfer, reporting, archiving, repeat-image handling, cleaning, and downtime response.Clinical use should define modality-specific cases, patient volume, reporting workflow, emergency use, contrast workflow where relevant, and image storage/retrieval expectations.
Technical complianceSpecify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS.Acceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.
Service readinessBiomedical should review QA/phantom requirements, calibration, service access, error logs, software versions, high-cost component warranty, remote service, and downtime escalation.Common faults include detector/probe/coil failure, tube wear, chiller/HVAC problems, calibration drift, image artifacts, network/DICOM failures, workstation license issues, and high-cost board failures.
Lifecycle costImmunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.Replace when critical assays or reagents are discontinued, pack size/wastage makes testing uneconomic, pipetting/detection reliability declines, QC failures rise, or software/LIS/service support ends.

Immunoassay Analyzer: Site and Responsibility Matrix

ResponsibilityVendor Must StateHospital Must Confirm
Site readinessConfirm power, UPS policy, HVAC, shielding or MRI safety zoning, room size, control area, floor loading, delivery route, network drops, PACS/RIS readiness, and service clearance.Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.
Workflow and interfaceReview patient scheduling, preparation, acquisition, image reconstruction/review, DICOM transfer, reporting, archiving, repeat-image handling, cleaning, and downtime response.Radiology users should test positioning, protocol selection, image review, dose or safety indicators, report/export workflow, contrast workflow where applicable, and ergonomic impact during peak lists.
Accessories and consumablesInclude assay reagent packs, calibrators, controls, sample cups/racks, trigger/pre-trigger or wash solutions, solid waste containers, pipette consumables where used, UPS, barcode/LIS accessories, and startup menu stock.Immunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.
AcceptanceAcceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.Vendor can demonstrate full patient-to-PACS workflow, QA process, error-log/service process, software licenses, high-cost component coverage, and uptime response.

Checklist

Procurement checklist

  • Clinical use should define modality-specific cases, patient volume, reporting workflow, emergency use, contrast workflow where relevant, and image storage/retrieval expectations.
  • Specify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS.
  • Image-chain configuration, clinical application package, dose or safety controls where relevant, workstation/reporting workflow, DICOM/PACS/RIS connectivity, cybersecurity, and site planning requirements should be specified.
  • High-cost components such as tube, detector, probe, coil, workstation, injector head, chiller, software licenses, and service tools should have clear warranty and replacement pricing.
  • Confirm power, UPS policy, HVAC, shielding or MRI safety zoning, room size, control area, floor loading, delivery route, network drops, PACS/RIS readiness, and service clearance.
  • Immunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.
  • TCO includes high-cost components, room works, power/HVAC, QA tools, software licenses, service contract, tube/probe/coil/detector risk, downtime, upgrades, and PACS storage.

The Hospital Administration/Procurement/Biomedical Dept checks

  • Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS.
  • Separate mandatory clinical applications from optional software packages. Require site-planning documents, high-cost component warranty, DICOM testing, and acceptance image-quality baseline before award.
  • Vendor can demonstrate full patient-to-PACS workflow, QA process, error-log/service process, software licenses, high-cost component coverage, and uptime response.
  • Biomedical should review QA/phantom requirements, calibration, service access, error logs, software versions, high-cost component warranty, remote service, and downtime escalation.
  • Acceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.

FAQ

What should be mandatory in a Immunoassay Analyzer RFQ?

Specify assay menu and methodology, throughput and time to first result, random access/STAT handling, sample and reagent capacity, onboard refrigeration/stability, calibration/QC, reflex/rerun, biotin/interference information, waste, and LIS. Include assay reagent packs, calibrators, controls, sample cups/racks, trigger/pre-trigger or wash solutions, solid waste containers, pipette consumables where used, UPS, barcode/LIS accessories, and startup menu stock.

How should vendors be compared for Immunoassay Analyzer?

Use the hospital's assay-by-assay monthly volume to model pack wastage and reportable-test cost; validate STAT access, calibration/QC, reagent loading, maintenance, error recovery, and LIS. Vendor can demonstrate full patient-to-PACS workflow, QA process, error-log/service process, software licenses, high-cost component coverage, and uptime response.

What costs are often missed when buying Immunoassay Analyzer?

Immunoassay TCO is driven by assay pack cost and pack size, onboard expiry, calibrators/QC, trigger/wash consumables, maintenance, waste, low-volume test wastage, service response, and menu continuity.

What should be written into acceptance terms for Immunoassay Analyzer?

Acceptance should verify delivered configuration, software licenses, image quality baseline, dose or safety baseline where relevant, DICOM/PACS/RIS workflow, accessories, training, warranty, and PM schedule.

References and Standards

Related Resources